Next Article in Journal
Opposed Actions of PKA Isozymes (RI and RII) and PKC Isoforms (cPKCβI and nPKCε) in Neuromuscular Developmental Synapse Elimination
Previous Article in Journal
Dental Epithelial Stem Cells as a Source for Mammary Gland Regeneration and Milk Producing Cells In Vivo
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 8
Issue 11
10.3390/cells8111303
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Influence of (5′R)- and (5′S)-5′,8-Cyclo-2′-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System’s Nightmare

by
Bolesław T. Karwowski
DNA Damage Laboratory of the Food Science Department, Faculty of Pharmacy, Medical University of Lodz, ul. Muszynskiego 1, 90-151 Lodz, Poland
Cells 2019, 8(11), 1303; https://doi.org/10.3390/cells8111303
Submission received: 15 September 2019 / Revised: 21 October 2019 / Accepted: 22 October 2019 / Published: 23 October 2019
(This article belongs to the Section Cell Nuclei: Function, Transport and Receptors)
Browse Figures
Versions Notes

Abstract

:
DNA lesions are formed continuously in each living cell as a result of environmental factors, ionisation radiation, metabolic processes, etc. Most lesions are removed from the genome by the base excision repair system (BER). The activation of the BER protein cascade starts with DNA damage recognition by glycosylases. Uracil-DNA glycosylase (UDG) is one of the most evolutionary preserved glycosylases which remove the frequently occurring 2′-deoxyuridine from single (ss) and double-stranded (ds) oligonucleotides. Conversely, the unique tandem lesions (5′R)- and (5′S)-5′,8-cyclo-2′-deoxyadenosine (cdA) are not suitable substrates for BER machinery and are released from the genome by the nucleotide excision repair (NER) system. However, the cyclopurines appearing in a clustered DNA damage structure can influence the BER process of other lesions like dU. In this article, UDG inhibition by 5′S- and 5′R-cdA is shown and discussed in an experimental and theoretical manner. This phenomenon was observed when a tandem lesion appears in single or double-stranded oligonucleotides next to dU, on its 3′-end side. The cdA shift to the 5′-end side of dU in ss-DNA stops this effect in both cdA diastereomers. Surprisingly, in the case of ds-DNA, 5′S-cdA completely blocks uracil excision by UDG. Conversely, 5′R-cdA allows glycosylase for uracil removal, but the subsequently formed apurinic/apyrimidinic (AP) site is not suitable for human AP-site endonuclease 1 (hAPE1) activity. In conclusion, the appearance of the discussed tandem lesion in the structure of single or double-stranded DNA can stop the entire base repair process at its beginning, which due to UDG and hAPE1 inhibition can lead to mutagenesis. On the other hand, the presented results can cast some light on the UDG or hAPE1 inhibitors being used as a potential treatment.

Graphical Abstract

1. Introduction

The genetic information in each cell is written in the sequence of DNA bases. Its stability and reproducibility determine normal cell growth, function and the actual survival of species [1]. In this crucial molecule, DNA lesions are formed continuously as a result of exposure to environmental factors, ionisation radiation, metabolic processes, etc. [2]. Every day, between 10,000 and 1,000,000 DNA incidences of damage per cell are generated as a result of the activity of various factors [3]. That is to say, there are about 3 × 1017 natively formed lesions per hour in the whole human body [4]. As a consequence of the variety of lesions, specific nucleic acid repair machineries were developed during cell evolution [5]. However, the effectiveness and reliability of these systems are not 100%. Consequently, changes in a genome can appear, which can subsequently lead to undesirable processes such as carcinogenesis, ageing, etc. [6]. On the other hand, mutation can push evolution forward [7,8]. Moreover, the formation of DNA lesions in privileged sites is the main outcome of much chemotherapy and radiotherapy [9]. It should be pointed out that the structure of DNA damage formed during physiological processes is identical to that formed by external factors [10]. However, the frequency of clustered lesion (CL) formation in native condition is lower than that formed during radiation (Low and High LET radiotherapy) [11]. A clustered lesion formed in both strands of a double helix or a tandem lesion in single-strand are defined as two or more individual lesions within one or two helical turns of the DNA after the passage of a single radiation track [12]. These types of DNA lesions are not only harmful to cells in terms of the repair process (recognition and removal), but also in terms of their accumulation and the fact that they remain in genome for a long time. One hypothesis is that clustered lesions encounter a replication fork in the cell S-phase [13]. It has been found that it takes a cell a good deal longer to repair a cluster composed of dGoxo (7,8-dihydro-8-oxo-2′-deoxyguanosine) and 2-deoxyrionolactone lesions than a solitary lesion; moreover, the mutation frequencies increase dramatically—by up to 58% [14]. In addition, it has been demonstrated that with an increased distance between dGoxo, for example, the AP-site (apurinic or apyrimidinic site) and an SSB (single-strand break) in the structure of clustered lesions, the frequency of mutation decreases and the efficiency of the CL repair process increases [15]. In most cases, the presence of dGoxo in clustered lesions is responsible for mutation formation due to GCAT transversion. The majority of DNA damage formed in nuclei or mitochondria, independently of the source of lesion, is removed by base excision repair [16]. Two simple, successive hydrolysis processes start the whole DNA base repair machinery (Figure 1A).
The first reaction is catalysed by specific mono or bifunctional glycosylades [17]. The second is carried out by the apurinic/apyrimidinic site (AP) endonuclease as well as by the bifunctional glycosylase. Human AP-endonuclease-1 (hAPE1) has been found to be the major enzyme which incises a bi-stranded cluster composed of AP-sites [18]. Due to the sensitivity of AP towards environmental changes (temperature, pH, etc.), this molecule could be subject to self-elimination (β- or β,δ-elimination) [19,20]. In 1987, unusual DNA damage was detected in a mammalian cell, namely 5′,8-cyclo-2′-deoxypurines (cdPu). However, historically this type of lesion had been discovered earlier by Keck in 1968 [21,22,23]. This nucleoside modification possesses an additional covalent bond between the C5′ and C8 atoms of the same molecule. Significantly, cdPus are the product of hydroxyl radical action, which initiates a cyclisation reaction by C5′ hydrogen abstraction [24]. Since both moieties (sugar and base) of the nucleoside were modified, cdPus are assigned to a clustered/tandem lesion. The newly formed covalent bond makes the structure of cdPus extremely rigid and insensitive to known glycosylase action. Additionally, they are the pure substrates for polymerase. The 5′S diastereomer of 5′,8-cyclo-2′-deoxyadenosine (cdA) is the stopping point for DNA chain elongation by polymerases [25]. It has been also shown that DNA polymerase β (polβ) can efficiently bypass a 5′R-cdA, when this lesion is located in complementary strand to the DNA strand under repair but, as can be expected, inefficiently bypass a 5′S-cdA [26]. These findings were justified by the previous observation that both diastereomers of cdA located in CAG repeated motive, leads to complementary CTG sequence excision and therefore can be bypassed by polβ in the lagging strand [27]. The influence of 5′,8-cyclo-2′-deoxypurines, in both their diastereomeric forms, on other polymerase activity in humans (polymerase η and ι) and yeast (polymerase ζ), was reported by You et al. [28]. Moreover, RNA polymerase II was the subject of intensive studies toward 5′S-cdA overcome during the oligonucleotide transcription process [29].
Neither of the diastereomers of 5′,8-cyclo-2′-deoxypuries (DNA damage) is a substrate for the base excision repair process (BER) and they are both removed from the genome by nucleotide excision repair (NER). Brooks et al. have experimentally shown, using normal and mutant Chinese hamster ovary (CHO) cell extracts isolated from adult hamster brain tissue, that 5′S-cdA is repaired by a nucleotide but not the base excision repair system [30].
Additionally, Kuraoka et al. showed that the removal of 5′S-cdA and 5′R-cdA from DNA is, respectively, 40 and 150 times slower than cis-platin adduct (the chemotherapeutic agent used for the treatment of sarcomas and cancers of the testes, ovaries, bladder, head and neck, and lungs) [31,32]. The above results have been supported by experiments, which have shown that 5′R diastereomer of both 5′,8-cyclo-2′-deoxyadenoine/guanosine are better substrates for nucleotide excision repair machinery than their 5′S form [33]. It has also been shown that 5′S-cdA can influence the dU/AP-site repair process in a typical clustered lesion (bi-stranded). The inhibition of dU repair was observed at a distance of +/− 8 bases [34]. The significance of 5′,8-cyclo-2′-deoxypurines for genome stability and repair processes has been the topic of several review articles [35,36,37].
In this article, the role, influence and differences between both 5′R and 5′S diastereomers of 5′,8-cyclo-2′-deoxyadenosine (Figure 1B)—denoted as cdA on clustered lesion repair via BER machinery—are shown.

2. Materials and Methods

2.1. Oligonucleotide Synthesis and Purification

The oligonucleotides, whose sequence is given in Table 1, were synthesized and purified in the Bioorganic Chemistry Department, Polish Academy of Science, Lodz, Poland, on a Geneworld (K & A Laborgeraete GbR, Schaafheim, Germany) synthesizer and using nucleotide phosphoroamidites purchased from the ChemGenes Corporation (Wilmington, MA, USA).
The phosphoroamidite derivatives of (5′R)- and (5′S)-5′,8-cyclo-2′deoxyadenosine were synthetized as described previously by Romieu et al. [38]. The crude oligonucleotides were purified by HPLC using Varian analytics with UV detection at wavelengths λ = 260nm, Phenomenex (Synergi 4 μm Fusion-RP 80Å, 250 × 4.6 mm) C-18 column.

2.2. Oligonucleotide Concentration

The concentration of the obtained oligonucleotides was determined from a maximum of absorbance ~260nm using a Varian Cary 1.3E spectrophotometer (Varian, Brunn am Gebirge, Austria). The online oligonucleotide properties calculator: OligoCalc [39] was used for the extinction coefficient determination of the oligonucleotides.

2.3. Mass Spectroscopy of Oligonucleotides

All mass spectra were acquired in the negative-ion mode on a Waters Synapt G2-Si HDMS quadrupole time of flight hybrid mass spectrometer (Waters, Manchester, UK). Samples of the oligonucleotides were dissolved in 10 mM ammonium acetate with 50% acetonitrile to achieve a concentration of 0.1 OD/mL. Samples were injected into the source of the mass spectrometer using a syringe pump at a flow rate of 10 μL/min. The capillary voltage was set at 2.6 kV, the cone voltage was 40 V, the source temperature was 120 °C, the desolvation temperature was 400 °C, the cone gas was 30 L/h and the desolvation gas was 600 L/h. The data were collected in full-scan negative ion mode over a mass range of 50–2000 m/z. Data processing was performed with Waters MassLynx 4.1 software (deconvolution with MaxEnt1 function, Waters Corporation, Milfors, MA, USA). The calculated and found masses of oligonucleotides were, respectively, as follows:
12409.14/12409.82 Matrix; 12167.90/12168.25 Cont.dU(0); 12181.98/12182.42 Native; 12165.90/12166.30 ScdA(−7); 12165.90/12166.50 ScdA(−5); 12165.90/12166.46 ScdA(−3); 12165.90/12166.25 ScdA(−1); 12165.90/12166.75 ScdA(+1); 12165.90/12165.20 RcdA(−1); 12165.90/12165.70 RcdA(+1); 12180.90/12181.48 ScdA(+3); 12180.90/12181.54 ScdA(+5); 12180.90/12181.84 ScdA(+7).

2.4. Thermal ds-Oligonucleotide Stability—Melting Temperature Measurement

The melting temperatures (Tm) were assigned on a Varian Cary 1.3 E spectrophotometer (Varian) equipped with a multicell block and temperature controller. The required amounts of oligonucleotide strand and complementary strand (0.44 μM and 0.55 μM, respectively) were dissolved in 1 mL of 0.1 M NaCl with 0.01 M MgCl2 and hybridized by heating at 90 °C for 10 min followed by slow cooling (overnight). The melting profiles were acquired by measuring the absorbance at a wavelength of 260 nm as a function of temperature. The values, presented in Table 1 as Tm, were measured in a range of between 19 °C and 90 °C with 1.0 °C/min step and one minute of holding time.

2.5. Circular Dichroism Analysis of Double-Stranded Oligonucleotides

CD spectra were recorded with a Jasco J-815 dichrograph (JASCO, Easton, MD, USA) at room temperature using 0.1 cm quartz cuvettes and an oligonucleotide concentration of 0.5 μM, as this concentration permitted parallel UV measurements. The CD spectra were collected within the range of 200 to 400 nm with an integration time of 1 s, increment 1 nm, band width 1 nm, scanning speed 50 nm/min. The profiles of the obtained spectra are given in Figure S1.

2.6. Preparation of 5′-End-Labeled Oligonucleotides

The oligonucleotides (0.2 μM) were 5′-End-labelled using 3.2 units of T4 polynucleotide kinase (New England BioLabs, Ipswich, MA, USA) with 1.6 mCi (1.6 μL) [γ-32P]ATP (Hartman Analytic GmbH, Braunschweig, Germany) in 16 μL of buffer [70 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 100 mM KCl, and 1 mM β-2-mercaptoethanol] for 45 min at 37 °C. The protein denaturation was made by sample heating at 95 °C for five minutes. After incubation, the radiolabelled sample was filtrated through a MicroSpin G-25 column (GE Healthcare, Buckinghamshire, UK), at 6000 RPM/2 min, the residue evaporated to dryness. The residue was dissolved in 80 μL of pure H2O. The purity of the investigated oligonucleotides was examined on a 20% denaturing polyacrylamide gel.

2.7. Oligonucleotide Hybridisation and UDG and hAPE1 Digestion Assay with Subsequent Piperidine Treatment

The labelled oligonucleotide was hybridized, as described previously, with a 1.5-fold excess of the purified non-radiolabelled complementary strand in 80 μL pure H2O. UDG and hAPE1 were purchased from NEB (New England BioLabs Ipswich, MA, USA).
The general procedure of UDG and hAPE1 oligonucleotide treatment was as follows: 0.014 μM of oligonucleotides, for each reaction time, presented in Table 1, was dissolved in 5 μL of reaction buffer (pH 7.9 at 25 °C) containing potassium acetate (50 mM), Tris acetate (20 mM), and magnesium acetate (10 mM) DTT (1 mM). To preserve identical experiment conditions for all the presented studies, the amount of digested strand was the same for the single or double-stranded oligonucleotide that was used. The oligonucleotide solution was cooled down in an ice/water bath and the cooled mixture (5 μL) of digestion enzymes UDG and hAPE1 containing 0.6 unit of each was added. (The same buffer as above was used to make the protein solution.) The reactions were incubated at 37 °C for the required time.
After enzymatic treatment, each oligonucleotide sample, if necessary, was precipitated with cold ethanol (100 μL) and 2 μL of glycogen vortex and placed on dry ice for 30 min and subsequently centrifuged at 12,000 rpm for 30 min at 4°C. The ethanol was removed and the residue then dried under reduced pressure at room temperature. If necessary, to reveal the DNA lesions, the dry samples of each investigated oligonucleotide were treated with 100 μL of 1 M piperidine solution at 80 °C for 30 min. The piperidine was then removed under reduced pressure. The residues were dissolved in 7 μL of denaturing loading dye containing bromophenol blue and xylene cyanol, and subjected to electrophoresis on a 20% denaturing polyacrylamide gel containing 7 M urea in 1× TBE for 120 min at a constant power of 44 W. The results of the PAGE electrophoresis analysis were visualized by autoradiography. All the biochemical experiments were repeated three times to confirm that they were reliable and consistent. If necessary, Quantity One 1-D analysis software (Bio-Rad) was used to estimate the cleavage bands.

2.8. Theoretical Computation Methodology of ONIOM Studies

As a starting point for the theoretical study, the crystal structure of ds-DNA and UDG (1emh.pdb) was chosen [40,41]. Due to the complexity of the system, the following changes were made: the crystal water molecules were removed, the ds-DNA was reduced from a ninemer to a pentamer, the protein molecules were restricted only to amino acids from the enzyme active site and next to it. The negative charges of oligonucleotide phosphate groups were neutralized by the addition of protons. This strategy has been well documented as applicable to structural studies of nucleic acids [42,43]. The sequence of the double-stranded pentamer was d[GApUAT]*d[ATATC], the chosen amino acids were Ser273, Leu272 Pro271, Ser270, Pro269, His268, Ala267, Gly246, Ser247, Ser169, Pro168, Pro167, Phe158, Ala214, Gly143, Gl144, Asn204, Asp145, Pro146, Tyr147, His148 (see Figure S2). The protein part was frozen for all studies, leaving the ds-DNA part flexible. Due to the cost of the calculation, the ONIOM (Our own N-layered Integrated molecular Orbital and molecular Mechanic) strategy was applied [44,45]. Therefore, the structures of the mentioned systems were divided into high—HL (ds-DNA, B3LYP/6-31G*) and low—LL (protein part B3LYP/3-21G*) levels (layers) of calculation [46,47].
For appropriate nucleoside and hydrogen bond energy calculations, the phosphate or sugar-phosphate backbone was removed from the obtained structures, leaving suitable base pair systems with subsequent atom saturation with the necessary hydrogen atoms. The hydrogen atoms added for saturation were optimised at the B3LYP/6-31G* level of theory, with the position of all other atoms fixed. The optimized structures of the discussed oligonucleotide and UDG (the selected part of enzyme) complexes have been attached as PDB files to the Supplementary Materials, as follows: Cont_pdU.pdb—d[GApUAT]*d[ATATC]//UDG, ScdA(+1)SM.pdb—d[G(5′S-cA)pUAT]*d[ATATC]//UDG, ScdA(-1)SM.pdb—d[GApU(5′S-cA)T]*d[ATATC]//UDG, RcdA(+1)SM.pdb—d[G(5′R-cA)pUAT]*d[ATATC]//UDG and RcdA(-1)SM.pdb—d[GApU(5′R-cA)T]*d[ATATC]//UDG. All the calculations were performed in the gaseous phase with the Gaussian 09 (revision A.02, Gaussian Inc., Wallingford, CT, USA) software package [48]. The graphical vitalization of obtained pdf files were made using the Discovery Studio Visualizer v16.1.0.15350 (BIOVIA, San Diego, CA, USA) [49].

3. Results and Discussion

To prevent an unexpected mutation, during evolution the cell has developed defence systems which repair and remove effectively, in a reasonable time, a DNA lesion, which is possible mainly due to its “isolated” nature [50]. A good example, which is often used as a single damage model and precursor of AP-site or single-strand break, is 2′-deoxyuridine. This lesion can appear in the nucleus or mitochondrial DNA as a product of direct 2′-deoxycytidine deamination or can be inserted in the genome during polymerise action, etc. However, a clustered lesion is a challenge for the cell repair machinery. The cyclobutane pyrimidine dimer is one of the frequent tandem lesions formed under UV-B/C radiation, which during the repair process can lead to dU formation [51,52].
The commonly accepted nomenclature of the position of mutual lesions in a clustered lesion is as follows: if the DNA damage in one strand is oriented on the 3′-end to the reference lesion in a complementary oligonucleotide, the numbering is positive; if positioned on the 5′-end, then it is negative [53]. In these studies, the same rules have been used to appropriately describe tandem lesions. In terms of damage hierarchy, the dGoxo is repaired after modified pyrimidines like dU, thymine glycol and 5,6-dihydrothymine are removed from DNA [54]. Due to the complexity of CL in comparison to isolated damage, their “lifespan” in the genome is long enough to increase the probability of their appearance in a replication fork during the cell S-phase [55]. Georgakilas et al. have shown that local, multiple damaged sites composed by AP-sites are observed in the cell genome for two weeks. It can be concluded that the slowness of CL repair is the effect of double-strand damage disruption during replication [56]. Therefore, the accumulation of clustered lesions in the genome is significantly dangerous for highly proliferated cells. Additionally, clustered damage can appear in cellular DNA not only as a product of ionisation radiation, but also as a result of endogenous oxidative stress. Oxidative stress is defined as “an imbalance between ROS (reactive oxygen species) production and/or their elimination” [57]. It is important to mention that the amount of DNA damage increases in a cell with weaker repair machinery BER, NER, etc., which is related to the ageing process [58]. Therefore, it can be speculated that the level of CL in cells increases with a longer lifespan [59]. The most crucial point for BER machinery is the modified base recognition and its incision with subsequent AP-site formation (Figure 1A). These two processes can be disrupted by the presence of non-substrate nucleosides such as cdA in a tandem lesion layout [60]. It is important to mention here that no influence of cdA on the dU or AP-site removing from a bi-stranded clustered lesion was denoted [32].

3.1. The Influence of 5′R-cdA and 5′S-cdA on UDG and hAPE1 Activity

As a model for this study, dU was chosen as a well-established modification and convenient precursor of an AP-site. The specific glycosylase, UDG (uracil-DNA glycosylase), which is one of the most evolutionary preserved enzymes, removes dU from single and double-stranded DNA (ss-DNA, ds-DNA) by the pinch-push-plug-pull mechanism [61]. Moreover, dU is removed from ss-oligonucleotides three times as fast as from its bi-stranded equivalent [62]. On the other hand, UDG is a monofunctional glycosylase which leaves the linear continuous form of oligonucleotide after glycosidic bond hydrolysis (Figure 1A). Therefore, visualisation of its activity by PAGE radiograms analysis is problematic. Due to the fact that the presence of an AP-site in the genome is highly mutagenic, the influence of cdA on another step in the base repair system was taken into consideration in this study. The most active, common and specific mammalian endonuclease is hAPE1 [63]. As shown in Figure 1A, this enzyme removes the AP-site leaving the 3′ hydroxyl group available for polymerase action. Based on the above, for this study, twelve oligonucleotides with a tandem lesion (dU/cdA) were chosen and used for the investigation of the influence of cyclopurine on dU or AP-site incision, depending on their mutual position. For this purpose, the double and single-stranded forms of DNA were taken into consideration. The DNA sequences are presented in Table 1. The distance between an investigated lesion was changed at an interval of 2 bases, i.e., −/+7, −/+5, −/+3, −/+1. As a control, ss- and ds-DNA with single dU were used (ss-Cont.dU(0), ds-Cont.dU(0)).
In order to preserve the native conditions as much as possible, UDG and hAPE1 enzymes were used together. The main tenet of this concept was that if one of the proteins was non-active or its activity was disrupted or reduced by cdA, then no shorter oligonucleotide, or indeed, no single-strand break, would be observed. As shown in Figure 2 (Lines 12) in each experiment conditions, the incision of dU and a subsequent AP-site in control single or double-stranded oligonucleotides, ss-Cont.dU(0) and ds-Cont.dU(0) respectively, were observed, therefore, both enzymes remain active. Moreover, native ss-DNA and ds-DNA without any modification were not digested by enzymes and were stable during 1M piperidine treatment at 80 °C. Therefore, it can be concluded that the proposed Native oligonucleotide is resistant to each step of the experiments (Figure 2B–D, Lines 1). As mentioned above, the moieties of a clustered lesion (bi-stranded or single-stranded) can influence the mutual repair process, depending on the distances between them. Due to the above, the dU moiety was located at a distance from seven to one base from cdA in both its directions (Table 1). The product, linear continuous strand of lesion digestion by UDG from ds- or ss-DNA was invisible in PAGE analysis. Consequently, glycosydic bond hydrolysis was carried out in the presence of the AP-site nuclease—hAPE1. This enzyme recognizes the apurinic/apyrimidinic site in a double-stranded oligonucleotide; a single-strand form is not a convenient substrate for its activity [64]. Therefore, no difference in electrophoretic migration between the initial oligonucleotide and digestion product of all of the investigated ss-DNA was observed.
Based on the above, it can be concluded that cdA does not change the global spatial geometry of a linear oligonucleotide towards the hAPE1 substrate or spontaneous cleavage/rearrangement (Figure 2B). Such a situation forces the use of alternative methods for AP-site incision and single-strand break (SSB) detection. One well-established technique in the field of DNA damage is chemical digestion by 1 M piperidine [65]. The above reaction elucidates that uracil from the investigated clustered lesion (Table 1) is effectively removed by glycosylase from ss-oligo, if the distance between cdA and dU is equal to 3 bases or higher in both directions of 5′S-cdA. Surprisingly, when dU was shifted to the 5′-site of cdA (ss-ScdA(-1) and ss-RcdA(-1)), a complete loss of glycosylase activity was noted, irrespective of the cyclopurine diastereomeric forms, 5′S or 5′R (Figure 2C, Lines 5,7). The situation becomes markedly different when dU was attached to the 3′ hydroxyl group of cdAs. Both oligonucleotides ss-ScdA(+1) and ss-RcdA(+1) were suitable substrates for UDG. However, the digestion of the glycosidic bond within dU was slower for ss-ScdA(+1) than for the control and ss-RcdA(+1) oligonucleotides for which the rate of bond cleavage was at the same level (Figure 3). In the same experiment, UDG needs 30 min to achieve the same level of dU removal from ss-ScdA(+1) as for the ss-Cont.dU(0), and ss-RcdA(+1) oligonucleotides. This observation indicates that this type of tandem lesion should be characterised by a prolonged cell lifetime. It should be mentioned here that in some situations, the seemingly easy to remove dU (from the point of privilege flexibility of single-strand oligonucleotides) cannot be rejected from the genome, which subsequently can give rise to increases in mutation or the termination of replication process itself. Kuraoka et al. have shown that a 5′S-cdA diastereomer is the end point for known high fidelity polymerases [25].
The genetic information is written in the nucleobase sequence and stored in a compressed ds-DNA form, i.e., chromatin, in the nucleus. The amount of single-stranded DNA in the cell is rather low [66]. Moreover, most of the enzymes involved in carrying out different processes on DNA recognise and use the double helix as a substrate/template. In the second step of this study, hybridisation of previously investigated ss-oligonucleotides with a complementary strand was carried out. This allowed the verification of the influence of the discussed CL on the efficiency of the BER process on the double helix. The melting temperatures (Tm) measurement of ds-DNA show their stability in experimental conditions of 37 °C. Table 1 presents the Tm value of all the investigated duplexes [67]. It should be pointed out that the differences in stability between native ds-oligo (ds-Native) and that with a clustered lesion were in a range of 5 °C. The lowest melting temperature was measured for ds-ScdA(+5) at 76 °C. Subsequently, for the native and control ds-DNA, Tms were measured at 82 °C and 80 °C, respectively. Despite the differences not being so significant, a tendency could be noted: A) when the dU was placed on the 3′ side of 5′S-cdA, the stability of all the investigated oligonucleotides was noted at the same level (79 °C); and B) when dU was shifted to the 5′-end, the Tm value decreases from 80 °C for ds-ScdA(+1) to 76 °C for ds-ScdA(+7), as shown in Table 1. It should be pointed out that the Tm values measured for duplexes containing the opposite 5’R diastereomer of cdA, i.e., ds-RcdA(+1) and ds-RcdA(-1) were equal at 79.02 °C. These observations are in good agreement with previous theoretical studies, which indicated the domino effect in a ds-DNA structure forced by 5′S-cdA moiety in its 3′-end direction [34]. Conversely, the isomer 5′R of cdA left the internal parameters of the double helix as a hydrogen bond or stacking interactions at the same level as in the native B DNA form [68]. Due to the huge problem with 5′R diastereomer synthesis of both 5′,8-cyclo-2′-deoxypurines, as well as their insertion within the oligonucleotide, the experimental non-theoretical structural studies of ds-DNA (NMR) were made only for their commercially available 5′S form [69,70,71]. Fortunately, the crystal structure of (5′S)-5′,8-cyclo-adenosine (cA) was achieved, which justified some of the theoretical and biological studies; however, it should be pointed out that even for the rigidity and similarity of cdA and cA in DNA natively, only 5′,8-cyclo-2′-deoxyadenosine is present [72]. However, 5′R-cdA forces deformation of the external shape of the double helix spatial geometry similar to that provoked by cis-platin adduct [73]. Surprisingly, the CD spectra of ds-oligonucleotides ds-ScdA(-1), ds-ScdA(+1), ds-RcdA(−1), ds-RcdA(+1), ds-Native and ds-Cont.dU(0) showed the same profiles and shifts, in nm, of minimas and maximas: ~245 nm and ~275nm, respectively (Figure 4). The profiles of the obtained spectra are characteristic of the B form of DNA [74,75]. The above results have shown that the investigated oligonucleotides with clustered/tandem lesions can form a stable B-DNA duplex. It should be pointed out that the lack of a methyl group in thymidine (uracil can be perceived as unmethylated thymine) next to cdAs, probably allowed oligo to pack rigid cyclopurine nucleotides in an energetically privileged local double-strand geometry.
The same experiments for ss-DNAs were repeated for suitable double-stranded forms. As previously, when the distances between dU and 5′S-cdA were higher than one base, both enzymes UDG and hAPE1 exhibited similar activity; as for the control oligonucleotide, ds-Cont.dU(0) possessed a sole dU as a reference lesion (Figure 2D). The dU appearing next to the 5′ or 3′ site of 5′R- and 5′S-cdA did not show in the radiogram image any activity of either one or both of the examined proteins. To elucidate this phenomenon, each reaction mixture was treated by 1 M piperidine. As shown in Figure 2E, for almost all the ds-oligonucleotides except one, i.e., ds-RcdA(+1), the view was the same as in experiments without piperidine treatment. These results show that clustered lesions dUPO5′S-cdA and dUPO5′R-cdA in ds-oligo are not a convenient substrate for UDG, as in ss-oligo, too. Surprisingly, contrary to previous results, the appearance of 5′S-cdAPOdU in the double helix, ds-ScdA(+1), make the system indigestible or unrecognizable for uracil glycosidase. On the other hand, double-stranded oligonucleotide ds-RcdA(+1) (containing 5′R-cdAPOdU) was recognised and digested by UDG. However, a comparison of the experiment results with and without pyrimidine treatment show that even though a glycosydic bond in dU moiety of CL in ds-RcdA(+1) resulted in cleavage by UDG, the subsequently formed AP-site could not be incised by hAPE1 (Figure 2D,E; Lines 8). Moreover, increasing the experiment time by up to four hours did not bring about any benefits, leaving the picture of the radiogram unchanged (Figure 5A,B). The AP-site formed as part of CL in ds-RcdA(+1) remained stable. During the same experiment, the single-strand break within the reference oligonucleotide ds-Cont.dU(0) was formed within five minutes. Therefore, the appearance of clustered lesion types such as 5′R-cdAPOdU or 5′R-cdAPOAP can be highly mutagenic, as they stop hAPE1 activity and leave the undigested apurinic/apyrimidinic site in the genome for a long time. Moreover, due to the reactivity of the aldehyde group of the AP-site, a secondary reaction can take place, leading to an interstrand crosslink formation, for example [76].

3.2. Theoretical Study

Glycolytic activity of UDG depends on several structural factors which have been well described in Chattopadhyay’s article [61]. Careful analysis of the UDG and ds-DNA crystal structure (1emh.pdb) revealed that a double-stranded oligonucleotide mainly interferes with protein at the distance of three nucleotides (Figure 2F) of a digested strand, whereas the complementary strand interacts only with the intercalating leucine finger (Luciene 272) [40,77]. Due to the fact that the “push” process requires the breaking of hydrogen bonds between dU and the complementary base with subsequent loosening in adjacent base pairs, when hydrolysed by UDG, the 2′-deoxyuridine glycosidic bond is three times as fast in ss-oligonucleotide as within a double-stranded one [62]. Contrary to the above, in the single-stranded oligonucleotide, the critical point is only the “plug” stage of the digested machinery. At this point, the enzyme dU or an equivalent, for example pdU (pseudo 2′-deoxyuridine), is inserted into the catalytic pocket [78]. The structural requirements of this process are consistent for the double helix, too. As shown by experimental study after the one base distance crossing, the inhibition effect of cdA on UDG is negligible (Figure 2C–E). Due to the above, in this theoretical study only differences between ds-Cont.dU(0), ds-ScdA(−1), ds-ScdA(+1), ds-RcdA(−1) and ds-Rcd(+1) were considered. As a starting point, the crystal structure named 1emh.pdb was chosen [40]. 1emh is a complex of UDG and ds-oligonucleotide (decamer); moreover, it contains pseudo 2′-deoxyuridine in a glycosylase active pocket. For the geometry optimisation, the ONIOM strategy was used at the B3LYP/6-31G*//B3LYP/3-21G* level of theory. The B3LYP functional was applied due to its established position in the UDG mechanism description [41,79]. Moreover, the double-zeta basis sets (6–31 and 3–21) with a polarisation function were chosen to provide a good electrostatic/stacking interaction as well as a hydrogen bond description [80,81]. On account of the system’s complexity, the protein part was reduced and frozen only to amino acids directly connected or next to the double helix, as shown in the file Cont_pdU.pdb in the Supplementary Materials (Figure 2F). This part (protein) of the molecule was assigned as a low layer of ONIOM and calculated at the B3LYP/3-21G* level of theory. The ds-oligonucleotide part was reduced to a pentamer in which the sequence of the nucleobase was converted from d[GTpUAT]*d[ATAAC] to reference ds-oligo Cont.pdU: d[GApUAT]*d[ATATC]. The spatial geometry optimisation, at the above level of theory, of the initial complex, without changes, showed only negligible atom displacement. This allowed an investigation of the influence of cdA on pdU “digestion” without any changes in the complex structure, except the position and chirality of cdA, namely the position of the newly formed C5′-C8 covalent bond within cdA. Therefore, the d[GApUAT]*[ATATC], d[G(5′S-cA)pUAT]*[ATATC], d[GApU(5′S-cA)T]*[ATATC], d[G(5′R-cA)pUAT]*[ATATC] and d[GApU(5′R-cA)T]*[ATATC] ds-oligo can be assigned further as follows: Cont.pdU, ScdA(+1), ScdA(−1), RcdA(+1) and RcdA(−1), respectively. The distance in Å between the 3′ and 5′ phosphate group of pdU for all the investigated structures were as follows: 6.13 Cont.pdU, 6.83 ScdA(+1), 5.31 RcdA(+1), 7.56 ScdA(−1), 6.05 RcdA(−1) (PDB files: Cont_pdUSM, ScdA(+1)SM, ScdA(−1)SM, RcdA(+1)SM, RcdA(−1)SM), as shown in Figure 6A−C. As shown, the distance for RcdA(+1) was the shortest, even shorter than for the Cont.pdU ds-oligo; therefore, dU digestion by glycosylase (the pinch stage) should be at least at the same level as for the control ds-oligo. Moreover, the pseudo 2′-deoxyuridine in each optimised structure was observed in the catalytic site of UDG. This indicates that if pdU was inserted into the enzyme active pocket, the glycosidic bond should be hydrolysed. The distance in Å between amino acid (carbonyl group) Asparagine 145 (D145) (directly responsible for dU glycosidic bond hydrolysis) and C1’ of pdU was found as follows: 5.07 d[G(5′S-cA)pUAT], 4.90 d[GApU(5′S-cA)T], 4.78 d[G(5′R-cA)pUAT], 4.64 d[GApU(5′R-cA)T] and 4.68 d[GApUAT], as shown in Figure 6A–C. This observation—the discussed distance increase from 4.68 Å in d[GApUAT] to 5.07 Å in d[G(5′S-cA)pUAT]—allows some basis for an explanation of why dU is not digested in the case of ds-ScdA(+1). In this instance, the inhibition of UDG activity by 5′S-cdAs, derived from the spatial hindrance forced by the rigid structure of 5′,8-cyclo-2′-deoxyadenosine, makes the ds-oligo unpalatable for the pinch-push-plug-pull mechanism. In this case, the hydrogen bond between cdA and thymidine must be traded off to allow the leucine finger to insert dU in the active UDG pocket. Originally, in cdAs, independently of the diastereomeric form 5′S or 5′R, the 2′-deoxyribose adopted the west (4′O-exo) conformation [82]. Moreover, two-dimensional NOESY NMR studies show that the spatial geometry of (5′S)-5′,8-cyclo-2′-deoxyadenosine is stable at a temperature range of between 25 °C and 41 °C [83]. Careful analysis of the investigated complex elucidated that the sugar moiety in 5′S-cdA and 5′R-cdA adopted the less favourable conformation (3′C-exo) in ds-oligo, denoted as ds-ScdA(-1) and ds-RcdA(-1), as shown in Table 2.
Conversely, when the pdU was attached to the 3′-end of cdA, the 2′-deoxyribose ring in the cyclic nucleoside adopted the privileged conformation 4′O-exo. As shown in Table 2, all the geometrical parameters, i.e., phase, amplitude, puckering and the υ2 dihedral angle calculated for the UDG complex with ds-ScdA(+1) and ds-RcdA(+1), adopted similar values to those obtained for solely nucleosides opposite to constructs possessing ds-ScdA(−1) and ds-RcdA(−1) oligos [73]. Moreover, the 5′,8-cyclo-2′-deoxyadenosine fitting into a suitable protein cave (determined by the amino acids Leu272, Ser273, Ser247, Gly246, Ala267, Gln144, His268) require energy changes at levels of 15 kcal and 18 kcal in the cases of ds-ScdA(−1) and ds-RcdA(−1), respectively (Table 3, Figure 6D−F). Contrary to that, the discussed differences were found to be less than 1 kcal and ~4 kcal for ds-ScdA(+1), ds-RcdA(+1) and Cont.pdU ds-oligo respectively (Table 3). The above results obtained for oligonucleotides in which pdU is attached to 5′-end of 5′S-cdA or 5′R-cdA are in good agreement with previous experimental results.
Additionally, the above observations indicate that in the clustered lesion repair process, the enzyme activity depends on “what” is directly attached to the 3′-OH group of the removed DNA damage. These notifications coincide with previous studies about the enzymatic processing of DNA containing tandem dihydrouracil [84]. As has been shown, UDG is less sensitive to the moiety attached to the 5′-end of dU. These phenomena can be explained by the fact that on this site of ds-oligo, the structure of the protein cave is much more flexible and malleable, therefore the rigid structure of cdAs can be accommodated. The following distances in Å between diagnostic amino acids His148/Pro168 and the phosphate group (5′-cdAPOpdU-3′) of ds-ScdA(+1), ds-RcdA(+1) and ds-Cont.pdU were measured as follows: 6.14/4.18, 3.48/6.32 and 6.1/4.22, respectively (Figure 6A–C). These results did not explain why dU is not digested from ds-ScdA(+1), although, based on theoretical studies, it should be. The stability of double-stranded oligonucleotides mainly depends on the stacking interaction and hydrogen bonds formed by complementary nucleobases. Moreover, their energy can allow other molecules, such as intercalators, to penetrate the internal structure of the double helix. The activity of UDG increases as the double helix structure loosens due to a depression of the energy barrier for leucine finger intercalating. The mechanism of the UDG action starts from the “push” point in which the amino acid Leu272 begins to flip out of the dU complementary base and starts to intercalate between the two adjacent base pairs [61]. During this process, the hydrogen bond formed by dU is broken, additionally the adjacent base pairs HB in reference ds-oligo (Cont.pdU) become gently debilitated in comparison to the isolated one by 0.9 and 3.76kcal, depending on its position in relation to dU, i.e., +1 or −1 respectively (Table 4).
This clearly shows that UDG is much more sensitive to the changes in the DNA part attached to the 3′-end of dU than to that which is adjacent to its 5′-end. Surprisingly, the energy of the base pair hydrogen bonds formed by 5′,8-cyclo-2′-deoxyadenosine in the protein nucleotide complexes ScdA(+1), ScdA(−1) and RcdA(−1) drastically decreased by up to five kcal. This energy change indicates that pdU, in the above cases, “snuggling down” in the glycosylase active site requires an expenditure of at least 11 kcal. In addition to this value, 17.79 kcal should be added to the U::A HB energy estimated for the isolated base pair. All of this makes the dU recognition process by UDG unprivileged in the light of enzyme fidelity. Therefore, in view of the experiment’s results, in the discussed cases, single-strand breaks were not observed (Figure 2C). The situation is the reverse in the case of ds-RcdA(+1) digestion by UDG. The energy change in the cdA::T hydrogen bond adjacent to pdU, which occurred in a hydrolytic cave, registered only a negligible deviation from the value found for the native base pair dA::dT (Table 4), and hypothetically makes the “glycosidic” bond of pdU in ds-RcdA(+1) suitable for hydrolysis. These theoretical results are in excellent agreement with data obtained empirically for ds-RcdA(+1), as shown in Figure 2E.

4. Conclusions

The frequencies of clustered lesions in cell tissue increase as the dose of radiation—Low- or High- LET—increases. This type of genome injury constitutes a significant challenge for the repair systems BER, NER, HEJ, NHEJ, etc. From a molecular pharmacology point of view, during cancer chemotherapy or radiotherapy treatments, such DNA modifications are highly desirable. Therefore, the quest for selective DNA repair protein inhibition is of major scientific interest. In this article, it has been shown that tandem lesion moieties separated by more than one base abolish the inhibition effect of 5′,8-cyclo-2′-deoxyadenosie on UDG, and subsequently on hAPE1 activity. This phenomenon might be derived from the fact that only a small part of oligonucleotide (three nucleotides) crucially and directly interact with the UDG surface, i.e., d[…XPOUPOX…] in both single and double-stranded DNA forms.
The results of enzymatic digestion of eight ss-DNAs and the corresponding ds-DNAs, as presented in Table 1, reveal the following:
-
the attaching of 5′S or 5′R cdA to the dU 3′ hydroxyl group in a single-stranded oligo completely blocks UDG activity opposite to the cdA adjacent to the dU 5′-end, allowing UDG glycosidic bond hydrolysis.
-
probably due to steric hindrance caused by 5′S-cdA in ss-ScdA(+1), dU glycosidic bond hydrolysis is slower than that found for ss-RcdA(+1) and the reference ss-DNA (Cont.dU(0)).
-
as shown in Figure 2C,E, both the 5′S and 5′R diastereomers of cdA inhibit uracil release from the ds-RcdA(−1) and ds-ScdA(−1) oligos. Surprisingly, only ds-RcdA(+1) is a substrate for 2′-deoxyuridine glycosylase and no digestion was observed for ds-ScdA(+1). The distance extent between 5′S-cdA and dU ranges from −/+3 to −/+7 and probably further base pairs abolished the inhibition effect on glycosylase. Moreover, these tandem lesions were recognised as a good substrate for further AP-site lysis by hAPE1.
-
the AP-site formed during ds-RcdA(+1) digestion by UDG was identified as an unsuitable substrate for hAPE1.
Finally, it should be pointed out that the appearance of the discussed tandem lesion in the structure of single or double-stranded DNA can stop the entire base repair process at its beginning, which due to hAPE1 inhibition can lead to mutagenesis. On the other hand, these results can cast some light on the UDG or hAPE1 inhibitors being used as a potential treatment.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4409/8/11/1303/s1. Figure S1: CD spectra of investigated ds-oligonucleotidestitle, Figure S2: The graphical representation of selected amino acids extracted from 1emh.pdb file, Figure S3: Spectra of Oligonucleotide Mass Spectrometry Analysis, Table S1: Sequence of oligonucleotides, Tables S2: The raw data presented by graphs on Figure.3. Average and corresponding standard deviations values, PDB files: Cont_pdU.pdb, RcdA(+1)SM.pdb, RcdA(-1)SM.pdb, ScdA(+1)SM.pdb, ScdA(-1)SM.pdb and Selected aminoacids indication in 1emh structure.msv.

Author Contributions

B.T.K. 100%.

Funding

This study was supported by the Medical University of Lodz (503/3-045-02/503-31-002), National Science Center, Poland (Grant No. 2016/23/B/NZ7/03367) and in part by PL-Grid infrastructure (Prometheus, ACC Cyfronet AGH).

Conflicts of Interest

The author declare no conflict of interest.

References

  1. Travers, A.; Muskhelishvili, G. DNA structure and function. FEBS J. 2015, 282, 2279–2295. [Google Scholar] [CrossRef] [PubMed]
  2. Tubbs, A.; Nussenzweig, A. Endogenous DNA damage as a source of genomic instability in Cancer. Cell. 2017, 168, 644–656. [Google Scholar] [CrossRef] [PubMed]
  3. Lindahl, T. Instability and decay of the primary structure of DNA. Nature 1993, 362, 709–715. [Google Scholar] [CrossRef] [PubMed]
  4. Shrinivas, S.A.; Shanta, S.H.; Prajakta, B.B. DNA: Damage and repair mechanisms in humans. Glob. J. Pharm. Sci. 2017, 3, 1–8. [Google Scholar]
  5. Chatterjee, N.; Walker, G.C. Mechanisms of DNA damage, repair and mutagenesis. Environ. Mol. Mutagen. 2017, 58, 235–263. [Google Scholar] [PubMed]
  6. Barnes, J.L.; Zubair, M.; Kaarthik, J.; Poirier, M.C.; Martin, F.L. Carcinogens and DNA damage. Biochem. Soc. Trans. 2018, 46, 1213–1224. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Livnat, A. Interaction-based evolution: how natural selection and nonrandom mutation work together. Biol. Direct. 2013, 8, 1–53. [Google Scholar] [CrossRef]
  8. Bernatchez, L. On the maintenance of genetic variation and adaptation to environmental change: considerations from population genomics in fishes. J. Fish. Biol. 2016, 89, 2519–2556. [Google Scholar] [CrossRef]
  9. Nickoloff, J.A.; Boss, M.-K.; Allen, C.P.; LaRue, S.M. Translational research in radiation-induced DNA damage signaling and repair. Transl. Cancer Res. 2017, 6, 875–891. [Google Scholar] [CrossRef]
  10. De Bont, R.; van Larebeke, N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 2004, 19, 169–185. [Google Scholar] [CrossRef] [Green Version]
  11. Goodhead, D.T. The initial physical damage produced by ionizing radiations. Int. J. Radiat Biol. 1989, 56, 623–634. [Google Scholar] [CrossRef] [PubMed]
  12. Eccles, L.J.; O’Neill, P.; Lomax, M.E. Delayed repair of radiation induced clustered DNA damage: Friend or foe? Mutat Res. 2011, 711, 134–141. [Google Scholar] [CrossRef] [PubMed]
  13. Georgakilas, A.G.; O’Neill, P.; Stewart, R.D. Induction and repair of clustered DNA lesions: what do we know so far? Radiat. Res. 2013, 180, 100–109. [Google Scholar] [CrossRef] [PubMed]
  14. Cunniff, S.; O’Neill, P.; Greenberg, M.M.; Lomax, M.E. Reduced repair capacity of a DNA clustered damage site comprised of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 2-deoxyribonolactone results in an increased mutagenic potential of these lesions. Mutation Res. 2014, 762, 32–39. [Google Scholar] [CrossRef]
  15. Pearson, C.G.; Shikazono, N.; Thacker, J.; O’Neill, P. Enhanced mutagenic potential of 8-oxo-7,8-dihydroguanine when present within a clustered DNA damage site. Nucleic. Acids Res. 2004, 32, 263–270. [Google Scholar] [CrossRef] [Green Version]
  16. Susan, S.; Wallace, S.S.; Murphy, D.L.; Sweasy, J.B. Base excision repair and cancer. Cancer Lett. 2012, 327, 73–89. [Google Scholar] [Green Version]
  17. Jacobs, A.L.; Schär, P. DNA glycosylases: in DNA repair and beyond. Chromosome 2012, 121, 1–20. [Google Scholar] [CrossRef]
  18. Abbotts, R.; Madhusudan, S. Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer. Cancer Treat. Rev. 2010, 36, 425–435. [Google Scholar] [CrossRef]
  19. Bailly, V.; Verly, W.G. The roles of beta-and delta-eliminations in the repair of AP sites in DNA. In DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells; Lambert, M.W., Laval, J., Eds.; NATO ASI Series; Springer: Boston, MA, USA, 1989; Volume 182, pp. 19–23. [Google Scholar]
  20. Osakabe, A.; Arimura, Y.; Matsumoto, S.; Horikoshi, N.; Sugasawa, K.; Kurumizaka, H. Polymorphism of apyrimidinic DNA structures in the nucleosome. Sci. Rep. 2017, 7, 41783. [Google Scholar] [CrossRef] [Green Version]
  21. Keck, K. Bildung von cyclonudleotiden bei bestrahlung wassiriger losungen von purinenucleotiden. Z. Nat. 1968, 23, 1034–1043. [Google Scholar]
  22. Dizdaroglu, M. Free-radical-induced formation of an 8,5′-cyclo-2′-deoxyguanosine moiety in deoxyribonucleic acid. Biochem. J. 1986, 238, 247–254. [Google Scholar] [CrossRef] [PubMed]
  23. Dizdaroglu, M.; Dirksen, M.L.; Jiang, H.X.; Robbins, J.H. Ionizing-radiation-induced damage in the DNA of cultured human cells. Identification of 8,50-cyclo-2-deoxyguanosine. Biochem. J. 1987, 241, 929–932. [Google Scholar] [CrossRef] [PubMed]
  24. Karwowski, B.T.; Grand, A.; Cadet, J. 5′,8-Cyclo-2′-deoxyadenosine (cdA) formation by γ-radiation. Theoretical quantum mechanics study. Acta Biochim. Pol. 2009, 56, 655–662. [Google Scholar] [CrossRef] [PubMed]
  25. Kuraoka, I.; Robins, P.; Masutani, C.; Hanaoka, F.; Gasparutto, D.; Cadet, J.; Wood, D.R.; Lindhal, T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 2001, 52, 49283–49288. [Google Scholar] [CrossRef] [PubMed]
  26. Jiang, Z.; Xu, M.; Lai, Y.; Laverde, E.E.; Terzidis, M.A.; Masi, A.; Chatgilialoglu, C.; Liu, Y. Bypass of a 5′,8-cyclopurine-2′-deoxynucleoside by DNA polymerase β during DNA replication and base excision repair leads to nucleotide misinsertions and DNA strand breaks. DNA Repair 2015, 33, 24–34. [Google Scholar] [CrossRef] [PubMed]
  27. Xu, M.; Lai, Y.; Jiang, Z.; Terzidis, M.A.; Masi, A.; Chatgilialoglu, C.; Liu, Y. 5′,8-cyclo-2′-deoxypurine lesion induces trinucleotide repeat deletion via a unique lesion bypass by DNA polymerase β. Nucleic Acids Res. 2014, 42, 13749–13763. [Google Scholar] [CrossRef]
  28. You, C.; Swanson, A.L.; Dai, X.; Yuan, B.; Wang, J.; Wang, Y. Translesion Synthesis of 8,5-Cyclopurine-2-deoxynucleosides by DNA Polymerases η, ι, and ζ. J. Biol. Chem. 2013, 288, 28548–28556. [Google Scholar] [CrossRef]
  29. Walmacq, C.; Wang, L.; Chong, J.; Scibelli, K.; Lubkowska, L.; Gnatt, A.; Brooks, P.J.; Wangb, D.; Kashleva, M. Mechanism of RNA polymerase II bypass of oxidative cyclopurine DNA lesions. Proc. Natl. Acad. Sci. USA 2015, 112, 410–419. [Google Scholar] [CrossRef]
  30. Brooks, P.J.; Wise, D.S.; Berry, D.A.; Kosmoski, J.V.; Smerdon, M.J.; Somers, R.L.; Mackie, H.; Spoonde, A.Y.; Ackerman, E.J.; Coleman, K.; et al. The Oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine Is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275, 22355–22362. [Google Scholar] [CrossRef]
  31. Kuraoka, I.; Bender, C.; Romieu, A.; Cadet, J.; Wood, R.D.; Lindahl, T. Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. USA 2000, 97, 3832–3837. [Google Scholar] [CrossRef]
  32. Mir, O.; Ropert, S.; Goldwasser, F. Cisplatin as a cornerstone of modern chemotherapy. Lancet Oncol. 2009, 10, 304. [Google Scholar] [CrossRef]
  33. Kropachev, K.; Ding, S.; Terzidis, M.A.; Masi, A.; Liu, Z.; Cai, Y.; Kolbanovskiy, M.; Chatgilialoglu, C.; Broyde, S.; Geacintov, N.E.; et al. Structural basis for the recognition of diastereomeric 5′,8-cyclo-2′-deoxypurine lesions by the human nucleotide excision repair system. Nucleic Acids Res. 2014, 42, 5020–5032. [Google Scholar] [CrossRef] [PubMed]
  34. Karwowski, B.T.; Bellon, S.; O’Neill, P.; Lomax, M.E.; Cadet, J. Effects of (5′S)-5′,8-cyclo-2′-deoxyadenosine on the base excision repair of oxidatively generated clustered DNA damage. A biochemical and theoretical study. Org. Biomol. Chem. 2014, 43, 8671–8682. [Google Scholar] [CrossRef] [PubMed]
  35. Chatgilialoglu, C.; Ferreri, C.; Geacintov, N.E.; Krokidis, M.G.; Liu, Y.; Masi, A.; Shafirovich, V.; Terzidis, M.A.; Tsegay, P.S. 5′,8-Cyclopurine lesions in DNA damage: chemical, analytical, biological, and diagnostic significance. Cells 2019, 8, 513. [Google Scholar] [CrossRef] [PubMed]
  36. Chatgilialoglu, C.; Ferreri, C.; Terzidis, M.A. Purine 5′,8-cyclonucleoside lesions: chemistry and biology. Chem. Soc. Rev. 2011, 40, 1368–1382. [Google Scholar] [CrossRef] [PubMed]
  37. Brooks, P.J. The 8,5′-cyclopurine-2′-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair 2008, 7, 1168–1179. [Google Scholar] [CrossRef]
  38. Romieu, A.; Gasparutto, D.; Cadet, J. Synthesis and characterization of oligonucleotides containing 5′,8-cyclopurine-2′-Deoxyribonucleosides: (5′R)-5′,8-cyclo-2′-deoxyadenosine (5′S)-5′,8-cyclo-2′-deoxyguanosine, and (5′R)-5′,8-cyclo-2′-deoxyguanosine. Chem. Res. Toxicol. 1999, 12, 412–421. [Google Scholar] [CrossRef]
  39. Kibbe, W.A. OligoCalc: An online oligonucleotide properties calculator. Nucleic Acids Res. 2007, 35. [Google Scholar] [CrossRef]
  40. Parikh, S.S.; Walcher, G.; Jones, G.D.; Slupphaug, G.; Krokan, H.E.; Blackburn, G.M.; Tainer, J.A. Uracil-DNA glycosylase-DNA substrate and product structures: conformational strain promotes catalytic efficiency by coupled stereoelectronic effects. Proc. Natl. Acad. Sci. USA 2000, 97, 5083–5088. [Google Scholar] [CrossRef]
  41. Dinner, A.R.; Blackburn, G.M.; Karplus, M. Uracil-DNA glycosylase acts by substrate autocatalysis. Nature 2001, 413, 752–755. [Google Scholar] [CrossRef]
  42. Gu, J.; Xie, Y.; Schaefer, H.F. Electron attachment to nucleotides in aqueous solution. Chem. Phys. Chem. 2006, 7, 1885–1887. [Google Scholar] [CrossRef] [PubMed]
  43. Gu, J.; Xie, Y.; Schaefer, H.F. Electron attachment to DNA single strands: gas phase and aqueous solution. Nucleic Acids Res. 2007, 35, 5165–5172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Dapprich, S.; Komáromi, I.; Byun, K.S.; Morokuma, K.; Frisch, M.J. A new ONIOM implementation in Gaussian98. Part, I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives. J. Mol. Struct. 1990, 462, 1–21. [Google Scholar] [CrossRef]
  45. Lin, H.; Truhlar, D.G. Redistributed charge and dipole schemes for combined quantum mechanical and molecular mechanical calculations. J. Phys. Chem. A 2005, 109, 3991–4004. [Google Scholar] [CrossRef] [PubMed]
  46. Hehre, W.J. Ab Initio Molecular Orbital Theory. Acc. Chem. Res. 1976, 9, 63–101. [Google Scholar] [CrossRef]
  47. Rugne, E.; Gross, E.K.U. Density-Functional Theory for Time-Dependent Systems. Phys. Rev. Lett. 1984, 52, 997–1000. [Google Scholar]
  48. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision, A.02; Gaussian Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
  49. BIOVIA. Discovery Studio Visualizer; v16.1.0.15350; BIOVIA: San Diego, CA, USA, 2015. [Google Scholar]
  50. Tokuyama, Y.; Furusawa, Y.; Ide, H.; Yasui, A.; Terato, H. Role of isolated and clustered DNA damage and the post-irradiating repair process in the effects of heavy ion beam irradiation. J. Rad. Res. 2015, 56, 446–455. [Google Scholar] [CrossRef]
  51. Mouret, S.; Baudouin, C.; Charveron, M.; Favier, A.; Cadet, J.; Douki, T. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc. Natl. Acad. Sci. USA 2006, 103, 13765–13770. [Google Scholar] [CrossRef] [Green Version]
  52. Barak, Y.; Cohen-Fix, O.; Livneh, Z. Deamination of cytosine-containing pyrimidine photodimers in UV-irradiated DNA. Significance for UV light mutagenesis. J. Biol. Chem. 1995, 270, 24174–24179. [Google Scholar] [CrossRef]
  53. Lomax, M.E.; Cunniffe, S.; O’Neill, P. 8-OxoG retards the activity of the ligase III/XRCC1 complex during the repair of a single-strand break, when present within a clustered DNA damage site. DNA Repair 2004, 3, 289–299. [Google Scholar] [CrossRef]
  54. Bellon, S.; Shikazono, N.; Cunniffe, S.; Lomax, M.; O’Neill, P. Processing of thymine glycol in a clustered DNA damage site: mutagenic or cytotoxic. Nucleic Acid. Res. 2009, 37, 4430–4440. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Gollapalle, E.; Wang, R.; Adetolu, R.; Tsao, D.; Francisco, D.; Sigounas, G.; Georgakilas, A.G. Detection of oxidative clustered DNA lesions in X-irradiated mouse skin tissues and human MCF-7 breast cancer cells. Radiat. Res. 2007, 167, 207–216. [Google Scholar] [CrossRef] [PubMed]
  56. Georgakilas, A.G.; Bennett, P.V.; Wilson, D.M. Sutherland BM. Processing of bistranded abasic DNA clusters in γ-irradiated human hematopoietic cells. Nucleic Acids Res. 2004, 32, 5609–5620. [Google Scholar] [CrossRef] [PubMed]
  57. Moreira, P.I.; Nunomura, A.; Nakamura, M.; Takeda, A.; Shenk, J.C.; Aliev, G.; Smith, M.A.; Perry, G. Nucleic acid oxidation in Alzheimer disease. Free Rad. Biol. Med. 2008, 44, 1493–1505. [Google Scholar] [CrossRef] [Green Version]
  58. Leandro, G.S.; Sykora, P.; Bohra, V.A. The Impact of Base Excision DNA Repair in Age-Related Neurodegenerative Diseases. Mutat Res. 2015, 776, 31–39. [Google Scholar] [CrossRef]
  59. Muller, F.L.; Lustgarten, M.S.; Jang, Y.; Richardson, A.; Van Remmen, H. Trends on oxidative angina theories. Free Radic. Biol. Med. 2007, 43, 477–503. [Google Scholar] [CrossRef]
  60. Brooks, P.J. The cyclopurine deoxynucleosides: DNA repair, biological effects, mechanistic insights, and unanswered questions. Free Radic. Biol. Med. 2017, 107, 90–100. [Google Scholar] [CrossRef]
  61. Schormann, N.; Ricciardi, R.; Chattopadhyay, D. Uracil-DNA glycosylases-structural and functional perspectives on an essential family of DNA repair enzymes. Protein Sci. 2014, 23, 1667–1685. [Google Scholar] [CrossRef]
  62. Slupphaug, G.; Eftedal, I.; Kavli, B.; Bharati, S.; Helle, N.M.; Haug, T.; Levine, D.W.; Krokan, H.E. Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. Biochemistry 1995, 34, 128–138. [Google Scholar] [CrossRef]
  63. Li, M.; Wilson, D.M. Human Apurinic/Apyrimidinic Endonuclease 1. Antioxid. Redox Signal. 2014, 20, 678–707. [Google Scholar] [CrossRef] [Green Version]
  64. Gros, L.; Ishchenko, A.A.; Ide, H.; Elder, R.H.; Saparbaev, M.K. The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway. Nucleic Acids Res. 2004, 32, 73–81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Margolin, Y.; Dedon, P.C. A general method for quantifying sequence effects on nucleobase oxidation in DNA. Methods Mol. Biol. 2010, 610, 325–340. [Google Scholar] [PubMed]
  66. Ashton, N.W.; Bolderson, E.; Cubeddu, L.; O’Byrne, K.J.; Richard, D.J. Human single-stranded DNA binding proteins are essential for maintaining genomic stability. BCM Mol. Biol. 2013, 14, 1–20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Breslauer, K.J.; Frank, R.; Blocker, H.; Marky, L.A. Predicting DNA duplex stability from the base sequence. Proc. Natl. Acad. Sci. USA 1986, 83, 3746–3750. [Google Scholar] [CrossRef] [PubMed]
  68. Karwowski, B.T. The role of (5′R) and (5′S) 5′,8-cyclo-2′-deoxyadenosine in ds-DNA structure: A comparative QM/MM theoretical study. Comput. Chem. 2013, 1010, 38–44. [Google Scholar]
  69. Zaliznyak, T.; Lukin, M.; de los Santos, C. Structure and stability of duplex DNA containing (5′S)-5′,8-cyclo-2′-deoxyadenosine: an oxidatively generated lesion repaired by NER. Chem. Res. Toxicol. 2012, 25, 2103–2111. [Google Scholar] [CrossRef]
  70. Huang, H.; Das, R.S.; Basu, A.K.; Stone, M.P. Structure of (5′S)-8,5′-cyclo-2′-deoxyguanosine in DNA. J. Am. Chem. Soc. 2011, 133, 20357–20368. [Google Scholar] [CrossRef]
  71. Huang, H.; Das, R.S.; Basu, A.K.; Stone, M.P. Structures of (5′S)-8,5′-cyclo-2′-deoxyguanosine mismatched with dA or dT. Chem. Res. Toxicol. 2012, 25, 478–490. [Google Scholar] [CrossRef]
  72. Haromy, T.P.; Raleigh, J.; Sundaralingam, M. Enzyme-bound conformations of nucleotide substrates. X-ray structure and absolute configuration of 8,5′-cycloadenosine monohydrate. Biochemistry 1980, 19, 1718–1722. [Google Scholar] [CrossRef]
  73. Takahara, P.M.; Rosenzweig, A.C.; Frederick, C.A.; Lippard, S.J. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 1995, 377, 649–652. [Google Scholar] [CrossRef]
  74. Gray, D.M.; Ratliff, R.L.; Vaughan, M.R. Circular dichroism spectroscopy of DNA. Methods Enzymol. 1992, 211, 389–406. [Google Scholar] [PubMed]
  75. Miyahara, T.; Nakatsuji, H.; Sugiyama, H. Helical structure and circular dichroism spectra of DNA: A theoretical study. J. Phys. Chem. 2013, 117, 42–55. [Google Scholar] [CrossRef] [PubMed]
  76. Yang, Z.; Price, N.E.; Johnson, K.M.; Wang, Y.; Gates, K.S. Interstrand cross-links arising from strand breaks at true abasic sites in duplex DNA. Nucleic Acids Res. 2017, 45, 6275–6283. [Google Scholar] [CrossRef]
  77. Barrett, T.E.; Sawa, R.; Panayotou, G.; Barlow, T.; Brown, T.; Jiricny, J.; Pearl, L.H. Crystal structure of a G:T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell 1998, 92, 117–129. [Google Scholar] [CrossRef]
  78. Zharkov, D.O.; Mechetin, G.V.; Nevinsky, G.A. Uracil DNA glycosylase: structural, thermodynamic and kinetic aspects of lesion search and recognition. Mutat. Res. 2010, 685, 11–20. [Google Scholar] [CrossRef]
  79. Gokey, T.; Hang, B.; Guliaev, A.B. Cadmium(II) inhibition of human uracil-DNA glycosylase by catalytic water supplantation. Sci. Rep. 2016, 6, 1–11. [Google Scholar] [CrossRef]
  80. Dong, H.; Hua, W.; Li, S. Estimation on the Individual Hydrogen-Bond Strength in Molecules with Multiple Hydrogen Bonds. J. Phys. Chem. A. 2007, 111, 2941–2945. [Google Scholar] [CrossRef]
  81. Gil, A.; Branchadell, V.; Bertran, J.; Oliva, A. An analysis of the different behavior of DNA and RNA through the study of the mutual relationship between stacking and hydrogen bonding. J. Phys. Chem. B 2009, 113, 4907–4914. [Google Scholar] [CrossRef]
  82. Altona, C.; Sundaralingam, M. Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. J. Am. Chem. Soc. 1972, 94, 8205–8212. [Google Scholar] [CrossRef]
  83. Karwowski, B.T.; Gaillard, J.; Granda, A.; Cadet, J. Effect of (5′S)-5′,8-cyclo-2′-deoxyadenosine on the conformation of di and trinucleotides. A NMR and DFT study. Org. Biomol. Chem. 2008, 6, 3408–3413. [Google Scholar] [CrossRef]
  84. Venkhataraman, R.; Donald, C.D.; Roy, R.; You, H.J.; Doetsch, P.W.; Kow, Y.W. Enzymatic processing of DNA containing tandem dihydrouracil by endonucleases III and VIII. Nucleic Acids Res. 2001, 29, 407–414. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Cells 08 01303 g001 550
Figure 1. (A) Graphical representation of base excision repair system’s (BER) initial step. Difference between mono- and bi-functional glycosylases action; and (B) structure of two cdA diastereomes: 5′R and 5′S.
Figure 1. (A) Graphical representation of base excision repair system’s (BER) initial step. Difference between mono- and bi-functional glycosylases action; and (B) structure of two cdA diastereomes: 5′R and 5′S.
Cells 08 01303 g001
Cells 08 01303 g002 550
Figure 2. Autoradiograms of denaturing PAGE: (A) the purity of ss-oligonucleotides; (B) ss-DNA digested by UDG and hAPE1; (C) ss-DNA digested by UDG and hAPE1 with subsequent 1M piperidine treatment; (D) ds-DNA digested by UDG and hAPE1; (E) ds-DNA digested by UDG and hAPE1 with subsequent 1M piperidine treatment (undigested ss-Native oligonucleotide as Line 0). Lines: 1) Native, 2) ScdA(-7), 3) ScdA(-5), 4) ScdA(-3), 5) ScdA(-1), 6) ScdA (+1), 7) RcdA(-1), 8) RcdA(+1), 8) ScdA(+3), 10) ScdA (+5), 11) ScdA(+7), 12) Cont.dU(0); (F) graphical representation of cdA spatial distribution around the UDG active site (dU) denoted as +1 or −1. The schematic view was built on the basis of a UDG and DNA complex crystal structure denoted as 1emh.pdb [40].
Figure 2. Autoradiograms of denaturing PAGE: (A) the purity of ss-oligonucleotides; (B) ss-DNA digested by UDG and hAPE1; (C) ss-DNA digested by UDG and hAPE1 with subsequent 1M piperidine treatment; (D) ds-DNA digested by UDG and hAPE1; (E) ds-DNA digested by UDG and hAPE1 with subsequent 1M piperidine treatment (undigested ss-Native oligonucleotide as Line 0). Lines: 1) Native, 2) ScdA(-7), 3) ScdA(-5), 4) ScdA(-3), 5) ScdA(-1), 6) ScdA (+1), 7) RcdA(-1), 8) RcdA(+1), 8) ScdA(+3), 10) ScdA (+5), 11) ScdA(+7), 12) Cont.dU(0); (F) graphical representation of cdA spatial distribution around the UDG active site (dU) denoted as +1 or −1. The schematic view was built on the basis of a UDG and DNA complex crystal structure denoted as 1emh.pdb [40].
Cells 08 01303 g002
Cells 08 01303 g003 550
Figure 3. (A) Digestion of single-stranded oligonucleotides: Cont.dU(0), ss-ScdA(+1) and ss-RcdA(+1) by UDG and hAPE1 with subsequent 1 M piperidine treatment. Lines 1–6 correspond to ss-Cont.dU(0); Lines 7–12 correspond to ss-ScdA(+1); Lines 13–18 correspond to ss-RcdA(+1). In all cases, the following order of reaction times was used: 0, 1, 5, 15, 30, 60 min starting from the left site. (B) Time scale for dU incision by UDG from ss-DNA containing a cluster lesion (The numeric raw data is presented in the graph, and the average and standard deviation values have been given a separate file in the Supplementary Materials). Sequence of single-stranded 40-mer oligonucleotides given in Table 1. (a) black points—ss-Cont.dU(0), (b) black squares—ss-ScdA(+1), (c) black triangles—ss-RcdA(+1).
Figure 3. (A) Digestion of single-stranded oligonucleotides: Cont.dU(0), ss-ScdA(+1) and ss-RcdA(+1) by UDG and hAPE1 with subsequent 1 M piperidine treatment. Lines 1–6 correspond to ss-Cont.dU(0); Lines 7–12 correspond to ss-ScdA(+1); Lines 13–18 correspond to ss-RcdA(+1). In all cases, the following order of reaction times was used: 0, 1, 5, 15, 30, 60 min starting from the left site. (B) Time scale for dU incision by UDG from ss-DNA containing a cluster lesion (The numeric raw data is presented in the graph, and the average and standard deviation values have been given a separate file in the Supplementary Materials). Sequence of single-stranded 40-mer oligonucleotides given in Table 1. (a) black points—ss-Cont.dU(0), (b) black squares—ss-ScdA(+1), (c) black triangles—ss-RcdA(+1).
Cells 08 01303 g003
Cells 08 01303 g004 550
Figure 4. CD spectra of investigated ds-oligonucleotides in 0.1 M NaCl with 0.01 M MgCl2. Line: ds-Cont.dU(0); ••• ds-Native; -- ds-RcdA(−1); ̶ • ̶ ds-ScdA(+1); ̶ •• ̶ ds-ScdA(−1); ̶ ̶ ds-RcdA(+1). (A large version of Figure 4 as well as separate CD spectra have been added to the Supplementary Materials as a separate file.).
Figure 4. CD spectra of investigated ds-oligonucleotides in 0.1 M NaCl with 0.01 M MgCl2. Line: ds-Cont.dU(0); ••• ds-Native; -- ds-RcdA(−1); ̶ • ̶ ds-ScdA(+1); ̶ •• ̶ ds-ScdA(−1); ̶ ̶ ds-RcdA(+1). (A large version of Figure 4 as well as separate CD spectra have been added to the Supplementary Materials as a separate file.).
Cells 08 01303 g004
Cells 08 01303 g005 550
Figure 5. Digestion of oligonucleotides ScdA(+1) and RcdA(+1) in double-stranded forms: (A) by UDG and hAPE1 and (B) by UDG and hAPE1 with subsequent 1M piperidine treatment. Lines 1–6 correspond to ds-Cont.dU(0); lines 7–12 correspond to ds-ScdA(+1); lines 13–18 correspond to ds-RcdA(+1). In each case, the following order of reaction times was used: 0, 5, 60, 120, 180, 240 min, starting from the left.
Figure 5. Digestion of oligonucleotides ScdA(+1) and RcdA(+1) in double-stranded forms: (A) by UDG and hAPE1 and (B) by UDG and hAPE1 with subsequent 1M piperidine treatment. Lines 1–6 correspond to ds-Cont.dU(0); lines 7–12 correspond to ds-ScdA(+1); lines 13–18 correspond to ds-RcdA(+1). In each case, the following order of reaction times was used: 0, 5, 60, 120, 180, 240 min, starting from the left.
Cells 08 01303 g005
Cells 08 01303 g006 550
Figure 6. Graphical representation of the distances in Å between the diagnostic amino acids His148/Pro168 and the phosphate group (5′-cdAPOpdU-3′), as well as pdU C1’ and His148 endocyclic nitrogen atom: (A) ds-Cont.pdU, (B) ds-ScdA(+1) and (C) ds-RcdA(+1). (D) The reference ds-oligonucleotide contains 2′-deoxyasdenosine (ds-Cont.pdU), (E) the oligonucleotide contains (5′S)-5′,8-cyclo-2′-deoxyadenosine (ds-ScdA(−1)), (F) the oligonucleotide contains (5′R)-5′,8-cyclo-2′-deoxyadenosine (ds-RcdA(−1)) fitting into a suitable protein cave, determined by the amino acids Leu272, Ser273, Ser247, Gly246, Ala267, Gln144, His268.
Figure 6. Graphical representation of the distances in Å between the diagnostic amino acids His148/Pro168 and the phosphate group (5′-cdAPOpdU-3′), as well as pdU C1’ and His148 endocyclic nitrogen atom: (A) ds-Cont.pdU, (B) ds-ScdA(+1) and (C) ds-RcdA(+1). (D) The reference ds-oligonucleotide contains 2′-deoxyasdenosine (ds-Cont.pdU), (E) the oligonucleotide contains (5′S)-5′,8-cyclo-2′-deoxyadenosine (ds-ScdA(−1)), (F) the oligonucleotide contains (5′R)-5′,8-cyclo-2′-deoxyadenosine (ds-RcdA(−1)) fitting into a suitable protein cave, determined by the amino acids Leu272, Ser273, Ser247, Gly246, Ala267, Gln144, His268.
Cells 08 01303 g006
Table
Table 1. Sequence of oligonucleotides containing 2′-deoxyuridine and 5′,8-cyclo-2′-deoxyadenosine and thermal stability (Tm) of corresponding duplexes.
Table 1. Sequence of oligonucleotides containing 2′-deoxyuridine and 5′,8-cyclo-2′-deoxyadenosine and thermal stability (Tm) of corresponding duplexes.
12345678910123456789201234567893012345678940Tm
[oC]
Matrix3′TAGAACAGTCCTTATAACAGAGATACGAGGGTGGTTTCCG
ScdA(-7)5′CTCTTGTCAGGAATATUGTCTCTcdATGCTCCCACCAAAGGC79.02
ScdA(-5)5′CTCTTGTCAGGAATATTGUCTCTcdATGCTCCCACCAAAGGC79.02
ScdA(-3)5′CTCTTGTCAGGAATATTGTCUCTcdATGCTCCCACCAAAGGC79.02
ScdA(-1)5′CTCTTGTCAGGAATATTGTCTCUcdATGCTCCCACCAAAGGC79.02
RcdA(-1)5′CTCTTGTCAGGAATATTGTCTCUcdATGCTCCCACCAAAGGC79.02
ScdA(+1)5′CTCTTGTCAGGAATATTGTCTCTcdAUGCTCCCACCAAAGGC80.00
RcdA(+1)5′CTCTTGTCAGGAATATTGTCTCTcdAUGCTCCCACCAAAGGC79.02
ScdA(+3)5′CTCTTGTCAGGAATATTGTCTCTcdATGUTCCCACCAAAGGC77.00
ScdA(+5)5′CTCTTGTCAGGAATATTGTCTCTcdATGCTUCCACCAAAGGC76.02
ScdA(+7)5′CTCTTGTCAGGAATATTGTCTCTcdATGCTCCUACCAAAGGC76.02
Cont.dU(0)5′CTCTTGTCAGGAATATTGTCUCTATGCTCCTACCAAAGGC76.02
Native5′CTCTTGTCAGGAATATTGTCTCTATGCTCCTACCAAAGGC82.00
U = 2′-deoxyuridine; cdA = 5′,8-cyclo-2′-deoxyadenosine; Tm = melting temperature. *A larger version of Table 1 is given in the Supplementary Materials as Table S1 docx file.
Table
Table 2. Sugar ring parameters (amplitude, phase puckering and dihedral angle values) of dA relaxed and extracted from optimized structure ds-DNA digested by UDG.
Table 2. Sugar ring parameters (amplitude, phase puckering and dihedral angle values) of dA relaxed and extracted from optimized structure ds-DNA digested by UDG.
Nucleosideυ2 *PhaseAmplitudeConformation
nucleoside relaxed
dA−32.67165.1133.80C2′-endo
5′R-cdA10.98283.2347.99O4′-exo
5′S-cdA10.92283.3547.31O4′-exo
nucleoside stressed
5′R-cdA(+1)−1.07268.7548.78O4′-exo
5′R-cdA(−1)−28.68236.6552.18C3′-exo
5′S-cdA(+1)−2.01267.5847.67O4′-exo
5′S-cdA(−1)−29.63235.6252.47C3′-exo
dA(+1)−27.20193.6827.99C2′-endo
dA(-1)−28.79178.1328.81C2′-endo
* dihedral angle υ2: C1’-C2′-C3′-C4′.
Table
Table 3. Energy difference in kcal between relaxed nucleosides extracted from ds-DNA: 2′-deoxyadenosine, (5′R) and (5′S)-5′,8-cyclo-2′-deoxyadenosine, calculated at the B3LYP/6-31G ** level of theory. Graphical representation (examples) of 5′,8-cyclo-2′-deoxyadenosine, spatial geometry, extracted from (A) ScdA(+1), (B) ScdA(−1) and the relaxed geometry of nucleosides: (C) 5′S-cdA, (D) dA.
Table 3. Energy difference in kcal between relaxed nucleosides extracted from ds-DNA: 2′-deoxyadenosine, (5′R) and (5′S)-5′,8-cyclo-2′-deoxyadenosine, calculated at the B3LYP/6-31G ** level of theory. Graphical representation (examples) of 5′,8-cyclo-2′-deoxyadenosine, spatial geometry, extracted from (A) ScdA(+1), (B) ScdA(−1) and the relaxed geometry of nucleosides: (C) 5′S-cdA, (D) dA.
Cells 08 01303 i001
NucleosidepdU Position +1pdU Position −1
5′S-cdA−0.61−15.91
5′R-cdA−0.37−18.16
dA−4.62−4.74
Table
Table 4. Next to UDGs’ active site AT base pair hydrogen bond energy, in kcal, presented in Figure 2F, calculated at the B3LYP/6-31G ** level of theory.
Table 4. Next to UDGs’ active site AT base pair hydrogen bond energy, in kcal, presented in Figure 2F, calculated at the B3LYP/6-31G ** level of theory.
cdA
Position to pdU		ds-DNA
Cont.pdUScdARcdA
+115.235.0514.88
−112.485.235.23
Unmodified AT base pair: 16.25. Unmodified AU base pair: 17.79.

Share and Cite

MDPI and ACS Style

Karwowski, B.T. The Influence of (5′R)- and (5′S)-5′,8-Cyclo-2′-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System’s Nightmare. Cells 2019, 8, 1303. https://doi.org/10.3390/cells8111303

AMA Style

Karwowski BT. The Influence of (5′R)- and (5′S)-5′,8-Cyclo-2′-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System’s Nightmare. Cells. 2019; 8(11):1303. https://doi.org/10.3390/cells8111303

Chicago/Turabian Style

Karwowski, Bolesław T. 2019. "The Influence of (5′R)- and (5′S)-5′,8-Cyclo-2′-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System’s Nightmare" Cells 8, no. 11: 1303. https://doi.org/10.3390/cells8111303

APA Style

Karwowski, B. T. (2019). The Influence of (5′R)- and (5′S)-5′,8-Cyclo-2′-Deoxyadenosine on UDG and hAPE1 Activity. Tandem Lesions are the Base Excision Repair System’s Nightmare. Cells, 8(11), 1303. https://doi.org/10.3390/cells8111303

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop